Receptors for small endogenous hormones on human leukocytes were studied by insolubilizing the hormones and incubating them with the cells. Histamine, norepinephrine, and prostaglandin E 2 (PGE 2 ) were conjugated to either of two types of carrier: (bovine or rabbit) serum albumin or a random copolymer of DL-alanine and L-tyrosine. The conjugates were linked to agarose beads (Sepharose) and the resultant drug-conjugate-beads were incubated with leukocytes. Norepinephrine (when linked to its carrier via glutaraldehyde) and histamine preparations bound the majority of leukocytes. The binding appeared to be specific for the hormones tested. For example, the binding by histamine-rabbit serum albumin-Sepharose was prevented or reversed by high concentrations of histamine and histamine antagonists, but not by catecholamines or their pharmacologic antagonists. Similarly, binding of cells to the norepinephrine conjugate was inhibited by some catecholamines and propranolol, but not by histamine or histamine antagonists. Conjugates of norepinephrine linked via carbodiimide did not bind cells. The protein or copolymer carriers did not contribute to binding per se. The hormone-protein-conjugates bound more cells than the hormone-polymer conjugates. The former (unlike the free amines) failed to stimulate accumulation of cyclic AMP in leukocytes. The norepinephrine linked to polymer via glutaraldehyde, however, did stimulate leukocyte cyclic AMP accumulation, possibly because of the flexibility of the polymer. Columns of the various Sepharoses were used to determine the distribution of […] 
A B S T R A C T Receptors for small endogenous hormones on human leukocytes were studied by insolubilizing the hormones and incubating them with the cells. Histamine, norepinephrine, and prostaglandin E2 (PGE2) were conjugated to either of two types of carrier: (bovine or rabbit) serum albumin or a random copolymer of DL-alanine and L-tyrosine. The conjugates were linked to agarose beads (Sepharose) and the resultant drug-conjugate-beads were incubated with leukocytes. Norepinephrine (when linked to its carrier via glutaraldehyde) and histamine preparations bound the majority of leukocytes. The binding appeared to be specific for the hormones tested. For Received for publication 30 August 1972 and in revised form 2 February 1973. tion of cyclic AMP in leukocytes. The norepinephrine linked to polymer via glutaraldehyde, however, did stimulate leukocyte cyclic AMP accumulation, possibly because of the flexibility of the polymer. Columns of the various Sepharoses were used to determine the distribution of receptors to each hormone in mixed leukocyte populations. The majority of cells appeared to have receptors for both histamine and norepinephrine (bound through glutaraldehyde). Receptors to prostaglandins may have been detected by the column procedure, but their distribution could not be quantitated. The approach described provides a means to separate leukocytes on the basis of what are likely to be preformed INTRODUCTION Basic methods have been devised to detect and chemically characterize cell surface receptors to hormones or antigens. One method involves insolubilization of the hormone, antigen, or hapten, preventing its entrance into the cell and allowing study of the function of the cell membrane or the intact cell when it makes contact with the chemical. Thus either the pharmacologic effect of the insoluble hormone agonist (1) (2) (3) , the detection of a receptor to antigen on selected cells of a suspension (4, 5) , or the distribution of the contact points of an antigen for its receptor on the cell can be studied (6) . A second and complementary approach has been to interact the radio-labeled substance with a cell containing the receptor and to determine the influence of [1349] [1350] [1351] [1352] [1353] [1354] [1355] [1356] [1357] [1358] [1359] [1360] [1361] labeled stubstances on the binding property of the labeled eheiical. The second approach has been used with perfusions of tissues, suspensions of cells or membranes and solubilized cell walls containing the receptors (7) (8) (9) (10) (11) ,
We have used aspects of both approaches in an attempt to study receptors for a series of small endogenous hormones on human leukocytes. In the past, using pharmacologic techniques, we have established the presence on human leukocytes of receptors for histamine, beta adrenergic catecholamines and the E series of prostaglandins. Each category of drug stimulated adenyl cyclase in mixed leukocytes. Antagonists of one class of agonist inhibited the effects of that class alone. Thus it was deduced that separate receptors existed for each group of agonists (12) (13) (14) (15) . Additional studies located receptors for histamine on the leukocyte surface (16) . To do this, histamine was first conjugated to a carrier (rabbit serum albumin [RSA] ,' bovine serum albumin [BSA] , or a synthetic random copolymer of alanine and tyrosine [P] ), and the multivalent conjugate was attached to agarose beads (Sepharose [S] ) (16) . When incubated with cells, the drug-conjugate-bead bound human leukocytes and leukocytes from several animal sources. The attraction appeared to be specific for histamine, because it was prevented by histamine antagonists and high concentrations of free histamine, but not by comparable concentrations of catecholamines or prostaglandins.
The purposes of this report are: (a) to describe the methods for synthesizing a random copolymer carrier and hormone-carrier conjugates, as well as the chemical manipulation that preserves the basic function of the bound primary amines; (b) to describe the pattern and evidence for specificity of binding of human peripheral 1Abbreviations used in this paper: BSA, or B, bovine serum albumin; cyclic AMP, cyclic 3'-5'-adenosine monophosphate; ECDI, 1-ethyl-3 (3-dimethylaminopropyl) carbodiimide HCl; H, histamine; MEM, Eagle's minimal essential medium; N, norepinephrine; P, copolymer of D-L-alanine and L-tyrosine; PBS, 0.15 M NaCl and 0.01 M sodium phosphate, pH 7.4; PGE1, PGE2, PGF2a, prostaglandin E1, E2, and F2,, respectively; RSA or R, rabbit serum albumin; S, Sepharose beads; H-B, H-P, H-R, conjugate of histamine with BSA, P, and RSA, respectively; Iso-R, conjugate of isoproterenol with RSA; N-B, N-R, conjugate of norepinephrine with BSA and RSA, respectively; PGE1-R, conjugate of prostaglandin E1 with RSA; PGE2-R, conjugate of prostaglandin E2 with RSA; PGF2a-R, conjugate of prostaglandin F2.a with RSA; H-R-S, N-R-S, PGE1-R-S, etc., and H-P-S, N-P-S, PGE1-P-S, etc., drug preparations linked by ECDI to carrier and then to S; H-P-S (GA), H-R-S (GA), drug preparations of histamine linked to PSepharose via glutaraldehyde and to RSA-Sepharose via glutaraldehyde, respectively; N-P-S (GA), N-R-S (GA), drug preparations of norepinephrine linked to P-Sepharose via glutaraldehyde and to RSA-Sepharose via glutaraldehyde, blood leukocytes by varioUs catecholamiftes of prostaglandin E2 conjugated to carriers and then bowid to Sepharose; (c) to compare the binding of cells to agonlists with the stimulation of leukocyte cyclic AMP ae cumulation; and (d) to describe the techniques employing columns of drug-conjugate-Sepharose that can be used to separate cells predominantly on the basis of a physiologic property-their preformed plasma membrane receptors for endogenous hormones. The process of separation may make it possible to analyze the distribution of the receptors on the cells for histamine and catecholamines.
METHODS
Synthesis and characterization of a random copolymer of alanine-tyrosine A linear copolymer of DL-alanine with L-tyrosine (P) was prepared by random copolymerization of N-carboxy-aamino acid anhydrides according to the method described by Sela and Fuchs (17) . The principal steps of the synthesis were to mix 14.5 g N-carboxy-DL-alanine anhydride (125 mmol) in 250 ml anhydrous dioxane with 5.15 g N-carboxy-L-tyrosine anhydride (25 mmol) in 150 ml dioxane and to initiate the polymerization by adding 0.6 g (5.1 mmol) of diaminohexane. The mixture was stirred vigorously at room temperature for 24 h. 800 ml of ether was added to complete precipitation of the polymer which had continuously and spontaneously precipitated in the dioxane. The polymer was then filtered and washed with 1 liter of ether. The yield of polymer in different batches varied from 13 to 15 g.
Amino acid analysis after acid hydrolysis revealed that the polymer had a residue molar ratio of DL alanine to L-tyrosine of 3: 1, and an average molecular weight of 1840, as established by ultracentrifugation using the method of Yphantis (v =0.73) (18) .
Low molecular weight and a random structure were properties desired for the polymer synthesized. The initiation of polymerization with diamine results in a copolymer with amines at each end. The general structure of the polymer is shown below:
where R represents the side chain of either tyrosine or alanine. Thus one terminal can be used to bind the polymer to Sepharose, while the other end is attached to the hormone. The distance between the two terminals is about 20 amino acids which was thought to provide a long enough flexible arm to accommodate to the stress of the receptorhormone interaction. Prostaglandin Es-RSA (PGEs-R). Prostaglandin E2 (a gift from Alza Corporation, Palo Alto, Calif.), 5 mg, was dissolved in 0.5 ml 20% ethanol/water and added to 60 mg RSA in 2 ml water. 12 mg ECDI were added to the mixture and the coupling allowed to proceed at room temperature for 24 h. The mixture was then dialyzed against two portions of 2,000 vol of water at 4°C. The amount of PGE2 coupled to RSA was determined by following the binding of 3H-labeled prostaglandin (New England Nuclear). About 20% was bound in the average batch, or 2.7 mol PGE2/mol RSA. 2 mg of the conjugate were linked to 1 g Sepharose. Prostaglandin was linked to the polymer using similar techniques.
Prostaglandin E1-RSA (PGE.-R) and prostaglandin F.a-RSA (PGF.a-R). These were prepared precisely the same way as PGE2-R.
Prostaglandin Ei-polymer Sepharose (PGEs-P-S). PGEs Synthesis of drug-protein or polymer conjugateSepharose: conjugate made with glutaraldehyde Histamine-RSA-Sepharose (GA) (H-R-S (GA)). Sepharose to which RSA was already linked (8 mg RSA/1 g Sepharose) was the starting material. 2 ml of the RSASepharose (50% suspension wt/vol) were reacted with 50 mg histamine dihydrochloride and 0.2 ml 50%o glutaraldehyde (GA) (Fluka). The mixture remained at room temperature for 16-20 h and was then washed on a sintered glass filter with 4 X 10 ml of water. The washed H-R-S was resuspended in 2 ml of water to which 50 mg NaBH4 (BDH Chemicals) were added. The total reduction of C = N bonds was associated with changing of the color of the mixture from yellow to white and was completed after 1 h when the Sepharose was washed with 2 X 10 ml of water. By this procedure 7.35 Amol histamine was bound to 1 g Sepharose (wet). Histamine-Polymer-Sepharose (GA) (H-P-S(GA)). Histamine dihydrochloride (50 mg) was mixed with 2 ml polymer-Sepharose (4 mg polymer/1 g Sepharose) suspension (50% wt/vol), and 0.2 ml 50% glutaraldehyde was added. The subsequent steps were as described above for H-R-S (GA).
Norepinephrine -R SA-Sepharose (GA) (N-R-S (GA)). Norepinephrine free base (25 mg) was dissolved in HCL. The pH was adjusted to 3.0. The solution was mixed with 2 ml (50% wt/vol) RSA-Sepharose (8 mg RSA/1 g Sepharose) to which 0.2 ml of 50%o glutaraldehyde was added. Subsequent steps were identical to H-R-S (GA). The most likely chemical configuration of the resultant drug-conjugate-Sepharose is shown in Fig. 1 . As shown in the figure, the norepinephrine is converted to a secondary amine, like that of epinephrine.
Norepinephrine-Polymer-Sepharose (GA)N-P-S (GA)).
The same amount of the free base of norepinephrine (as described above) was interacted with 2 ml (50%o wt/vol) of polymer-Sepharose (4 mg polymer/i g Sepharose) and glutaraldehyde (0.2 ml of 50% solution). Subsequent steps were identical to those described for H-R-S (GA).
Handling of human leukocytes
Venous blood of normal volunteers was subjected to sedimentation with 3% Dextran 250 (Pharmacia) in PBS, and the leukocytes were isolated as previously described (12, 21) . Plastic venipuncture tubes contained heparin (5 U/ml of blood) as an anticoagulant. After separation and one wash in cold 0.32 M sucrose, the cells were suspended in a convenient volume of either PBS or Eagle's Minimal Essential Medium (MEM) without glutamine (Microbiological Associates, Jerusalem). The differential count of cells prepared in this fashion was similar to that of stained smears from peripheral venous blood of the same subj ect. Contamination by platelets was of the order of 1 platelet per 15-20 leukocytes (12) .
Binding of leukocytes to Sepharose. Different batches of Sepharose beads (0.05 ml of a 25% suspension of agarose in PBS) were incubated with 5-10 X 106 leukocytes for 15 min with gentle shaking at 37°C. After incubation the mixture was gently resuspended and a portion of cells and the beads were examined under the microscope. 100 consecutive beads were examined from each specimen and scored as binding if they held 20 cells or more per bead, and as negative if fewer cells were bound. Two additional types of experiments were conducted. In one, the cells were incubated with each of several drugs at various concentration for 10 min at 370 before the Sepharose-drug conjugate was added, and then incubated for an additional 15 min. The binding of the beads was assessed. In the second type of experiment, the cells were incubated with a Sepharosedrug conjugate, and the free drugs were added after 15 min of incubation. The mixture was incubated for an additional 15 min and the binding was assessed. These latter experiments tested the ability of the drugs to displace cells after they had been bound to Sepharose.
Preparation of columns. 24 X 106 leukocytes were incubated with various Sepharoses (0.6 ml of a 25% suspension of agarose/PBS) for 15 min at 370C. The suspension was then poured into a plastic column (made from the lower 3 cm of 10 ml pipettes [Falcon Plastics, Los Angeles, Calif.]) containing a small sponge rubber plug at its tip. The columns were washed with 0.5 to 1.0 ml portions of PBS until the unbound cells were separated from the column. In some experiments the bound cells were eluted from the columns by adding 1 ml portions of various drugs, and gently shaking and resuspending the column contents with a Pasteur pipette (Fig. 5 ). In the experiments described in Table IV , sufficient numbers of columns of either R-S, H-R-S, or N-R-S(GA) were run to allow collection of 36 X 106 unbound cells that were divided into three portions. 1 portion was incubated with 0.3 ml of either R-S, H-R-S, or N-R-S(GA) suspensions. The incubates were then poured into columns as above and washed with PBS until the unbound cells were separated from the column. The unbound cells were counted and appropriate calculations made.
Leukocyte cyclic AMP concentrations. Leukocytes in PBS or MEM (6 X 107 cells/ml) were exposed to drugs or 0.6 ml of various Sepharoses or 0.5 ml of the supernatant from the Sepharose mixture for 15 min. At the end of the incubation, cells were separated from the medium by centrifugation at 800 g for 10 min at 0C. The cell pellet was resuspended in 1.2 ml, 5%o trichloroacetic acid. Cyclic AMP was extracted and measured by the competition binding assay of Gilman (22), slightly modified as previously described (15) .
RESULTS

Interactions of Sepharose preparations with leukocytes
Binding. By more than twice that in the GA conjugates, yet only the latter (N-R-S[GA]) bound cells. However, the approximate molarity of the prostaglandin Ea RSA-Sepharose preparation was lower than that of the other drug conjugates. This may have been responsible in part for the lack of apparent binding of cells to the prostaglandin Es (Table I) . The scoring of beads as positive or negative for binding is arbitrary and could be somewhat misleading. Several instances of binding of some cells were consistently seen with isoproterenol and PGE2 conjugates to RSA and Sepharose. However, because the number of cells was less than 20/bead, they were scored as negative.
Further characteristics of binding were studied using those Sepharose-drug conjugates that readily bound large numbers of cells, i.e., H-R-S, H-R-S(GA), and N-R-S (GA) ( Table I) . Binding of cells was pH dependent (Fig. 3) . Binding was maximal at about pH 7, T and sharply decreased at higher pH values for both tagonists of catecholamines. The general pattern of prevention of binding seen in H-R-S was also seen when using H-R-S(GA) or H-P-S. Once bound, cells could be displaced from the H-R-S by high concentrations of diphenhydramine or histamine-RSA (0.25 mg/ml incubate) (Fig. 4) . The displacement of H-R was not as complete as when the chemical was preincubated with cells before adding H-R-S (Fig. 4) (Table III) . To be certain that minor amounts of catecholamine were not being dissociated from the Sepharose, both the supernatant of N-P-S (GA) and the supernatant from incubations of the same preparation with leukocytes were tested, and neither altered cyclic AMP content of the cells. Furthermore, the stimulation by N-P-S(GA) was almost completely inhibited by propranolol (10' M), minimally inhibited by phentolamine and unaffected by four antihistamines all at 10-' M. None of four batches of Sepharose, activated Sepharose, R-S, P-S, H-R-S, H-R-S(GA), H-P-S, H-P-S(GA), Iso-R-S, or N-P-S stimulated cyclic AMP accumulation. Two preparations of PGE2-P-S but not PGE2-R-S stimulated cyclic AMP accumulation. Some of these results are shown in Table III .
H-R-S and N-R-S(GA). Binding of H-R-S differed from H-R-S(GA) in that the
Although the results with various batches of N-P-S-(GA) were not consistent, the unique augmentation of cyclic AMP accumulation by N-P-S (GA) suggests that the glutaraldehyde linking procedure had produced chemical and pharmacologic properties different from those resulting from the ECDI procedure. The glutaraldehyde procedure may have preserved some of the reactivity of the amino group, which in other systems is essential for adrenergic agonist activity. The likely structure of N-P-S(GA) (Fig. 1) probably preserves the basicity of the amine group. In addition, alkyl substitution of norepinephrine (producing a secondary amine) clearly enhances beta rather than alpha agonist activity in other systems (23) . The proposed structure (Fig. 1) for N-P-S(GA) provides just such an alkyl substitution, producing a catecholamine similar to epinephrine. Incidentally, further substitution (with ECDI or glutaraldehyde) of the amine group of isoproterenol and epinephrine (which are already secondary amines) would be expected to decrease agonist activity, by decreasing the basicity of the nitrogen atom (ECDI) or introducing steric hindrance (GA) at a site which is critical for intrinsic activity of the agonist (23) . Iso-R-S and H-R-S both failed to stimulate leukocyte cyclic AMP accumulation (Table III) . rather than to depend on visual scoring of binding; and (c) to devise a method by which cells with specific receptors could be recovered.
Sepharose-drug columns
Using H-R-S we found that the columns retained 82±+-7% of the cells, or 31% more than was retained by the R-S (Table IV) . Further, when the H-R-S column was washed extensively with PBS, pH 8.1, almost all of the retained cells were eluted from the column. More than 95% of the eluted cells excluded methylene blue dye and therefore were presumably viable. The recovery from H-R-S columns by elution with an antihistamine, diphenhydramine, was 29% (Fig. 5) . We have no way at present to determine whether some of the cells bound by R-S had histamine receptors or whether the great majority of cells with histamine receptors were specifically eluted by diphenhydramine. However, the similarity of 31% additional retention by H-R-S over R-S and the 29% elution of cells from H-R-S by an antihistamine is interesting. Propranolol (1 X 1O' M) did not displace cells from the H-R-S columns.
When columns were constructed from H-R-S(GA), pH changes did not increase elution of cells over that obtained by washing at pH 7.1. Diphenhydramine did elute about the same percentage of cells from H-R-S as from H-R-S (GA). Adrenergic antagonists had no effect, and because histamine was relatively inefficient in displacement of cells from beads, it was not tried in the experiments with columns.
N-R-S (GA) columns retained significantly more cells than R-S and about the same number as H-R-S. Only 15% of the total number were eluted by a gradient elution of 10 to 10' M propranolol. Surprisingly, only 8% of the total were eluted by washing with PBS at pH 8.5. Likewise there was no effect of the antihistamine pyrilamine on elution of cells from these columns.
Determination of the "distribution of receptors" in the population of cells was approached by sequential column experiments in which the unbound cells of the first column were passed (recycled) through a second column (Table IV) . About 50% of cells were retained by R-S. We consider this retention nonspecific because retention by Sepharose, activated Sepharose and R-S columns was equivalent. We have not been able to determine precisely how much retention is due to the RSA, the contiguous surface of beads, or the sponges or column material, or is a function of the volumes of fluid we use on the columns. When cells passed through the R-S were subsequently re-exposed to new batches of R-S, substantially fewer cells were retained. Regardless of which Sepharose-drug conjugate was used first, a lower percentage of cells was retained when the non-bound cells were rechromatographed on fresh batches of the same substance or R-S. In the four experiments in which the cells excluded from columns of H-R-S were chromatographed on R-S, practically no additional retention was seen. This seems to indicate that RSA may contribute to binding of cells that are also bound by H-R-S, but once cells which are bound by H-R-S columns are removed from the population, R-S will have little more effect.
The binding of cells excluded by an H-R-S column was only significant on N-R-S (GA). Conversely, the binding of cells excluded by N-R-S(GA) columns was only significant on H-R-S (Table IV) . This may indicate that a maximum of 21-30% of cells from the second column (4-6% of the total cell population) have receptors either to histamine alone or to catecholamine alone, but that the majority of cells bound probably have multiple receptors on them.
Columns constructed of PGE2-R-S were used in a similar set of sequential column experiments. These columns did not retain significantly more cells than R-S (57+5 vs. 51±2%, respectively). However, when cells excluded from an R-S column were exposed to a second column composed of PGE2-R-S, there was a small increase of binding on the PGE2-R-S compared with recycling on R-S. Preliminary experiments indicated that when PGE2-R-S served as the first column, a second PGE2-R-S column retained only a small additional percentage of cells (about 18%), whereas an H-R-S column retained 65% of the cells which were not bound by the prostaglandin column. These experiments suggest that the column procedure (in contrast to direct visualization, Table I ) may detect binding of cells to beads coated with prostaglandin. Since there is presently no specific procedure for displacing cells from PGE2-R-S, the presence of receptors to prostaglandins on cell surfaces must be established by more direct methods.
DISCUSSION
We describe methods which can be used to insolubilize vasoactive hormones. We intended to determine whether these preparations might be useful in detecting hormone receptors on a heterogeneous population of leukocytes. Studies with the hormone-carrier-bead preparations indicate they can bind cells. Whether or not the binding is via receptors for the free hormones on the plasma membrane remains to be seen. In one sense, the binding is "specific": the protein and polymer carriers alone attached to S did not bind or aggregate cells; binding was seen only when the hormones were attached to the carrier-bead preparation. However, the cells did not bind to hormone-carrier-bead preparations precisely as they would be expected to bind free hormone. The cells were displaced from hormone-containing beads, and binding to beads was prevented by the corresponding amine or relatively specific amine antagonists, but at concentrations higher than required for the agonists to stimulate cyclic AMP accumulation, or the antagonists to prevent it (13) (14) (15) . In addition, free norepinephrine at high concentrations did not significantly displace cells from the N-R-S(GA) ( Table II) . The When drugs were attached to the protein carriers, their binding properties were much more pronounced than when the copolymer was used (Fig. 6) . The most likely explanation for the difference in cell binding potency of the protein vs. polymer preparations is that the former has many drug molecules per mole and serves as a polyvalent attractant. In contrast, the copolymer has only 1 mol of drug per mole of polymer, so that the "density" of drug presented to the cell would be low. The fact that polyvalent attractants are more successful in holding a cell than univalent attractants also has its counterpart in immunologic experiments where multivalent carriers of hapten or antibody were more capable than univalent carriers of binding cells by their receptors (25) .
Studies using the copolymer as the carrier add to the understanding of the binding process. There is no qualitative difference in the characteristics of binding by histamine-polymer-Sepharose or histamine-protein-Sepharose. Yet the polymer is random. Therefore, the data provided by the polymer indicate that the length of the arm is probably its most important characteristic in allowing binding of cells to drug.
For some kinds of experiments, the polymer preparations may prove to have distinct advantages over the protein carriers. Only the N-P-S (GA) stimulated cyclic AMP accumulation in leukocytes, although the total number of moles of norepinephrine was much greater in N-R-S and N-R-S (GA) (See Table I ). Perhaps the polymer's simpler structure made it more flexible than a complex protein, thus allowing a better fit of hormone into the receptor site than could occur with the protein carrier. Accordingly, the polymer-conjugate could stimulate cell function but would not bind well, because it lacked polyvalent attractants. The protein conjugates, for the same reasons, would bind well but would fail to exert pharmacologic activity (elevation of cellular cyclic AMP). Although this explanation is attractive, it remains unproved, and does not explain the absence of pharmacologic activity of H-P-S or H-P-S (GA) preparations.
The polymer carrier has at least one additional advantage over the protein-carrier-drug conjugate. Because the polymer is short and has a simple structure and can be constructed with different functional groups on each terminal, it might be used in studies for mapping of receptors on individual cells. Thus, the carboxyl end of a polymer (synthesized but not reported here) could be attached to ferritin, dansyl, or other "indicator" molecules, and the amino end to the drug in question. Such studies are presently in progress. Finally, it is conceivable that in studies designed to purify receptors to the agonist drug by affinity chromatography, the mul-FIGURE 6 Schematic representation of the difference between the polyvalent H-RSA-S (left) and the univalent H-polymer-S (right).
tivalent protein carrier could be used to attract as much receptor material as possible, while the pharmacologically active polymer drug conjugate could be used if activation of an enzyme marker is advantageous.
Some advantages to systematic insolubilization of small hormones for the study of cell receptors are indicated. One advantage over the study of the interaction of free soluble radio-labeled drugs on cells or portions of cells is that only the surface properties of the cell are involved in the binding of the insolubilized drug. The experiments show that binding can be studied independent of the pharmacologic action of the drug.
Another advantage to studies with insolubilized drugs is that further characteristics of the drug-cell interaction can be deduced. The importance of the functional amino group of catecholamines or histamine is indicated by the contrast between the binding properties of norepinephrine or histamine conjugated to carrier by ECDI, and the properties of the same amines conjugated to the carrier via glutaraldehyde. Since isoproterenol is a potent stimulator of leukocyte adenyl cyclase, we would expect it to bind well to leukocytes. But when isoproterenol, a secondary amine, was coupled to succinic acid, either an hydroxyl group was changed or isoproterenol was converted to a tertiary amine.
With both histamine and norepinephrine, the primary amine is probably the functional group bound to carrier. Coupling with ECDI produces an amide bond between the amino group of the hormone and a carboxyl residue of either aspartic acid or glutamic acid of the protein (26); The binding process drastically reduces the basicity of the amino groups (27) . In contrast, coupling of the amino group of the hormone via glutaraldehyde (to free amino groups of the carrier) preserves the basic function of the hormonal amino group, since the imino (CH = N) bonds formed by interaction of the aldehyde with the amine group are completely reduced to alkyl amines by sodium borohydride (Fig. 1) .
Consequently, preservation of the basic amino function of norepinephrine in N-R-S(GA) may explain the imLeukocyte Receptors to Small Hormones pressive increase in its binding ability over that of N-R-S (an amide). In addition (as noted under Results), alkyl substitution of the amino group of norepinephrine in N-P-S(GA) may have increased its pharmacologic activity (ability to stimulate cyclic AMP production) by making it "look like" free epinephrine (an alkylated derivative of norepinephrine), which is a potent beta adrenergic agonist in leukocytes (13, 15) .
Our results may shed some light on the mechanism of binding of histamine to its receptor. Antihistamines are capable of preventing binding by, or displacing bound cells from, both histamine preparations (H-R-S and H-R-S(GA)). The fact that the leukocyte binding to insolubilized histamine does not depend on whether ECDI or glutaraldehyde is used as a linking agent may indicate that the imidazole portion of the molecule is of critical importance for recognition by a receptor, at least at pH 7.0 (Table II) . H-R-S, prepared with ECDI, would lack basicity at its side-chain nitrogen (27) , but would retain a basic nitrogen on the imidazole ring. The relatively low pKa of the imidazole nitrogen (5.97) would account for sharp reduction in the binding ability of H-R-S (Fig. 3) since, as pH is raised to 8, the positive charge would be lost. The glutaraldehyde linkage (H-R-S (GA)), however, would preserve positive charge (at pH 8 or 9) of the side chain amino group of histamine (pKa 9.8), and consequently the molecule's binding ability at higher pH values (Fig. 3) .
The basic function of the amino group of norepinephrine may be more critical to binding and pharmacologic effect than that of histamine, since histamine possesses alternate basic nitrogen groups in the imidazole portion which may add to the function of the primary amine: hence the failure of N-R-S to bind cells (Fig. 3) , since ECDI linkage has destroyed the amine's basicity. The pH dependence of binding to N-R-S (GA) (Fig. 3) could reflect preservation of the basic amino group. These observations may indicate that receptors to both histamine and norepinephrine contain ionized acidic groups, as have been found in the active site of acetylcholinesterase (28, 29) .
The experiments with columns may add useful dimensions to the approach we are describing. Although a drug-carrier-Sepharose preparation may not show binding of cells when examined under the microscope, the binding potential is increased when the columns are used. Further discriminatory power may be added to the detection of receptors when sequential columns are used. The distribution of receptors on a cell suspension was assessed. The majority of bound cells may contain both histamine and epinephrine receptors, while a small percentage of cells may have only one or the other receptor. Limitations of the method are also apparent, because if different cell groups have a spectrum of affinity for the hormone, it might be interpreted that the receptors did not exist on some cells only because cells were not bound by the drug-carrier-Sepharose preparation. At present another limitation of the method is that equivalent conjugation of all drugs on carriers has not been accomplished, and some negative experiments using Sepharose with a low drug/carrier molar ratio do not exclude the presence of receptors.
Finally, the columns may be able to be used to separate cells on the basis of their physiologic receptors even though the cells have relatively similar morphology. Subsequent studies of the unbound cells and cells eluted from the column may begin to define the function of both cells and their receptors (30) . It is also logical to assume that the same approach might be used in other systems with dispersed cells from other origins (31) .
